Zacks Investment Research
25 Feb 2026, 03:55 UTC · 32w ago
Verdict
Headline leans bullish. We score EVH +0.30 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.30moderately bullish
More positive than 62% of ticker scores this week
Search tags
What the story claims
4 claims · scored −1 bearish … +1 bullish
Evolent Health reported quarterly revenues of $468.72 million, missing the Zacks Consensus Estimate by 0.11% and falling sharply from $646.54 million in the year-ago period.
So whatA nearly 27.5% year-over-year revenue decline and slight top-line miss signal fundamental deterioration that is strongly negative for the stock's valuation.
More negative than 99% of claims this week
Evolent Health shares have lost approximately 30.8% since the beginning of the year, severely underperforming the S&P 500's decline of 0.1%.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 95% of claims this week
Over the last four quarters, Evolent Health has surpassed consensus EPS estimates just once and has topped consensus revenue estimates only twice.
So whatA poor track record of beating estimates undermines investor credibility and increases the risk discount applied to the company's forward guidance.
More negative than 91% of claims this week
Evolent Health reported quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share and improving from a loss of $0.02 per share a year ago.
So whatThe 28% earnings beat and year-over-year swing to profitability offers a modest positive signal, though it is overshadowed by severe revenue declines.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 62% of ticker scores this week
The company beat earnings estimates with a 28% surprise and returned to profitability compared to last year, despite a slight revenue miss.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
28m ago
+57.8%
Price agrees with the score
$4.04 vs $2.56 close before publication (Feb 24) · not market-adjusted
EVH chart →
